Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients - Wikidata - awgldk - TriplyDB

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

http://www.wikidata.org/entity/Q24561776

about

Oxidative stress and diabetic complications FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus.Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins.Glucose autoxidation induces functional damage to proteins via modification of critical arginine residues Involvement of Maillard reactions in Alzheimer disease.Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings Role of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus.Uremic Toxicity of Advanced Glycation End Products in CKD.Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice Novel insights in the treatment of diabetic nephropathy.A brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patients.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms Vascular calcification: pathophysiology and risk factors Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1.Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes.Evidence for non-enzymatic glycosylation in Escherichia coli.Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.Glycation and post-translational processing of human interferon-gamma expressed in Escherichia coli.

P2860

Q29615423-4D81C7B8-7512-4C71-8EB7-3FC8DCDCA25B Q30873486-2A401DB3-CC32-483C-8456-F15E39688143 Q33622283-D89C1997-3376-4BDA-9CE9-E87718F2CCAE Q34193025-93A45BC5-3FB8-4081-921C-3F92CC656477 Q34490546-435C6990-80B6-4B12-88A9-E703F7B076C8 Q34528130-3D638151-0DB4-4DF0-9A29-24AA1F45E76D Q35118391-8EDB8A11-9175-462B-A79E-06D634C68DA3 Q35164047-AF194E95-B465-45F0-8403-3ACA4A85917E Q35583145-D2EFDF77-1DD9-4FFC-B8B5-DE5ACEAF4DCC Q35636589-FCD8A20B-9AC8-4E21-9575-EDF3A70D9BD5 Q36320068-CC31146D-C939-4CA8-9CD2-8805FE50BD94 Q36514906-225FCE68-B917-47E8-B309-F4CCCAE6EB00 Q36578536-1B0A9E4A-C41B-4ECB-83A7-DE642E0298AF Q37070946-02E7AE27-83CD-48C3-BE7F-214B7F9297C3 Q37183301-2C4CC737-7852-49F6-AED6-4458E1A9998C Q37636453-FB6CD788-D337-4427-B238-B3746D58A2B3 Q37649134-589B6684-E242-424B-B153-B38A5E134BE2 Q40789140-8398B1E7-50B4-4516-A500-7E6666B087EE Q40789629-E1EB0D5B-3E56-4E08-AF26-0CC0C852A8F2 Q41886296-401443AA-1933-4428-9473-AEAABCFE3DF6 Q42544383-9C88E1D7-1261-4A44-B841-CEB4397C0C3B Q43544090-D5DC18D6-24CA-43BA-8AB5-71C5EB665141 Q46495572-15DF1E88-FB7D-4FA0-9E01-A8F7E350CF01 Q54517575-E96A00AD-8D47-4EE2-B705-C2FDF2D4D113

P2860

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

http://www.wikidata.org/entity/Q24561776

description

1997 nî lūn-bûn

@nan

1997 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի մարտին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Immunohistochemical detection ...... nd aortas of diabetic patients

@ast

Immunohistochemical detection ...... nd aortas of diabetic patients

@en

Immunohistochemical detection ...... nd aortas of diabetic patients

@nl

type

label

Immunohistochemical detection ...... nd aortas of diabetic patients

@ast

Immunohistochemical detection ...... nd aortas of diabetic patients

@en

Immunohistochemical detection ...... nd aortas of diabetic patients

@nl

prefLabel

Immunohistochemical detection ...... nd aortas of diabetic patients

@ast

Immunohistochemical detection ...... nd aortas of diabetic patients

@en

Immunohistochemical detection ...... nd aortas of diabetic patients

@nl

P1433

Q24561776-8DB9DFFF-3E6C-4695-8999-B37A8C824BE6

P1476

Q24561776-94D703E2-EC77-4AA7-810F-6BD76B7B3656

P2093

Q24561776-0CB0364F-6612-4866-8FD8-493B198281F3

Q24561776-1CB60025-0B4D-4547-9061-FEA14E21172B

Q24561776-1D731776-F59E-4750-B34F-C05B4177A38A

Q24561776-2AA8EF37-6D22-48EC-8599-1E9DD524366D

Q24561776-6B6CF046-09F8-4955-A24F-1810964F534C

Q24561776-6C4FD1A4-2211-443D-9755-E11FA06C44CB

Q24561776-933F3FC4-DEA9-4ADE-90B9-330F5411F54B

Q24561776-BF3E6397-DFCA-49A4-B44B-ECD142C622C4

P2860

Q24561776-09981083-B9E8-44A2-9E19-A62D97EB5EAE

Q24561776-156DD462-1467-4A91-8AA7-177AC34DABA1

Q24561776-1C46DCA3-9F59-42B2-8B0C-6F63105A7BCD

Q24561776-1D3AC3DC-A048-4A9D-908C-E4AEC1733A38

Q24561776-225CDECD-2157-40E8-BBC1-32D58762DF09

Q24561776-22D3F475-EB3A-4BE7-B41E-4DB368160412

Q24561776-2B922821-9991-4271-B142-5D4E008D3997

Q24561776-427BA064-84B1-4A70-96CE-79EFAB4C45A7

Q24561776-4838E652-0D15-4DED-A509-BEEF784C5E3A

Q24561776-48A57837-A480-4BFB-BACA-59D1B5F29FAD

P304

Q24561776-77CDDF73-5263-4654-BAB5-7F2BB865B842

P31

Q24561776-BF4BCF7F-CD09-4FEF-97A8-C0B4D9614F8F

P356

Q24561776-52DE8BA8-4AF1-470A-A03F-AC69C56DE5BD

P407

Q24561776-9C85B453-9DDA-4031-A18B-3320726AE636

P433

Q24561776-26795DB7-FC2B-4241-B62E-9A82B05C17DF

P478

Q24561776-9536488B-CD36-4202-A43E-4A22A41F7FC2

P577

Q24561776-C51BBB94-F7FF-44D2-8F78-25315F408F5D

P698

Q24561776-19E7D4F7-18B5-4592-8353-3BA0C4D58817

P921

Q24561776-ACF55A04-C4E8-4806-87C7-C8E51D6A8AA7

Q24561776-BE1DD6F7-CD19-4C21-9905-D3E54425E5C6

P932

Q24561776-8B94BB94-2790-4C99-8341-824FC31F7E8E

P356

P1433

Journal of Clinical Investigation

P1476

Immunohistochemical detection ...... nd aortas of diabetic patients

@en

P2093

F Hayase

http://www.w3.org/2001/XMLSchema#string

N Tatemichi

http://www.w3.org/2001/XMLSchema#string

S Miyazaki

http://www.w3.org/2001/XMLSchema#string

T Katsuzaki

http://www.w3.org/2001/XMLSchema#string

T Miyazaki

http://www.w3.org/2001/XMLSchema#string

T Niwa

http://www.w3.org/2001/XMLSchema#string

Y Ishizaki

http://www.w3.org/2001/XMLSchema#string

Y Takei

http://www.w3.org/2001/XMLSchema#string

P2860

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

Accelerated age-related browning of human collagen in diabetes mellitus

Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo

Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline

Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

Identification of fructose 3-phosphate in the lens of diabetic rats.

P304

1272-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI119285

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

1997-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9077536

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

507942

http://www.w3.org/2001/XMLSchema#string